4.6 Article

Process Analytical Technology (PAT) for Biopharmaceutical Products: Part II. Concepts and Applications

期刊

BIOTECHNOLOGY AND BIOENGINEERING
卷 105, 期 2, 页码 285-295

出版社

WILEY
DOI: 10.1002/bit.22529

关键词

process analytical technology (PAT); rapid microbiological techniques; lyophilization; NIR; chemometrics

向作者/读者索取更多资源

Implementing real-time product quality control meets one or both of the key goals outlined in FDA's PAT guidance: variability is managed by the process and 11 product quality attributes can be accurately and reliably predicted over the design space established for materials used, process parameters, manufacturing ring, environmental, and other conditions. The first part of the paper presented an overview of PAT concepts and applications in the areas of upstream and downstream processing. In this second part, we present principles and case studies to illustrate implementation of PAT for drug product manufacturing, rapid microbiology, and chemometrics. We further present Our thoughts on how PAT will be applied to biotech processes going forward. The role of PAT as an enabling component of the Quality by Design framework is highlighted. Integration of PAT with the principles stated in the ICH Q8, Q9, and Q10 guidance documents is also discussed. Biotechnol. Bioeng. 2010;105: 285-295. Published 2009 Wiley Periodicals, Inc.dagger

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Endocrinology & Metabolism

Assessing the Structural and Functional Similarity of Insulin Glargine Biosimilars

Gayatri Vishwakarma, Neh Nupur, Anurag S. Rathore

Summary: In this study, the structural and functional similarity of biosimilars of insulin glargine were evaluated. The results showed that some biosimilars had higher levels of high molecular weight species and related substances, as well as higher rates of impurity generation. The aggregation at 14 days was found to be correlated with the aggregation at 0 day and the number of months from expiry. Overall, insulin glargine biosimilars demonstrated similarity to the innovator product, but certain biosimilars exhibited low amounts of product-related variants that impacted product stability. The order of biosimilarity was Lantus((R)) > Biosimilar 2 > Biosimilar 4 > Biosimilar 1 > Biosimilar 3.

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY (2023)

Article Pharmacology & Pharmacy

FDA Warning Letters: A Retrospective Analysis of Letters Issued to Pharmaceutical Companies from 2010-2020

Anurag S. Rathore, Yuexia Li, Hemlata Chhabra, Akshat Lohiya

Summary: This study examines the reasons for warning letters issued by the FDA to pharmaceutical companies after post-approval inspections. The most common reasons for the warning letters are poor compliance to CGMP and misbranding. Detailed analysis of CGMP warning letters reveals three major types of violations: deficiencies in process validation, documentation practices (data integrity), and quality control. The study emphasizes the importance of improving CGMP compliance and implementing effective quality management systems to avoid warning letters.

JOURNAL OF PHARMACEUTICAL INNOVATION (2023)

Review Biotechnology & Applied Microbiology

Continuous integrated manufacturing for biopharmaceuticals: A new paradigm or an empty promise?

Anurag S. Rathore, Garima Thakur, Nikhil Kateja

Summary: Continuous integrated bioprocessing has gained significant attention from the biopharma industry, but its implementation in the biologics industry faces challenges due to legacy infrastructure, regulatory guidelines, and a focus on novel therapies. This article provides a review and perspective on the status and hurdles of continuous integrated bioprocessing. It suggests that the real impact of this technology may be seen when manufacturing costs become a significant portion of product development costs.

BIOTECHNOLOGY AND BIOENGINEERING (2023)

Review Biotechnology & Applied Microbiology

Artificial intelligence and machine learning applications in biopharmaceutical manufacturing

Anurag S. Rathore, Saxena Nikita, Garima Thakur, Somesh Mishra

Summary: Artificial intelligence and machine learning have vast potential in optimizing the design, monitoring, and control of biopharmaceutical manufacturing. The driving forces for adopting these techniques include the increasing global demand for biotherapeutics and the rise of Industry 4.0, which require intelligent, automated supervision. This review summarizes the applications of artificial intelligence and machine learning in biopharmaceutical manufacturing, focusing on commonly used algorithms such as multivariate data analysis, artificial neural networks, and reinforcement learning. Perspectives on the future growth of these applications and the challenges in implementing them at manufacturing scale are also discussed.

TRENDS IN BIOTECHNOLOGY (2023)

Article Biotechnology & Applied Microbiology

Long term culturing of CHO cells: phenotypic drift and quality attributes of the expressed monoclonal antibody

Rajinder Kaur, Ritu Jain, Niharika Budholiya, Anurag S. Rathore

Summary: The study investigates the impact of long term culturing on cell morphology and altered cellular functions, which may lead to phenotypic drift and affect product yield and quality. The study highlights the use of cellular and analytical assay toolbox to define cell line stability and optimize culture performance and product quality.

BIOTECHNOLOGY LETTERS (2023)

Article Biochemical Research Methods

High-throughput capillary electrophoresis analysis of biopharmaceuticals utilizing sequential injections

Ramesh Kumar, Deepika Sarin, Anurag S. S. Rathore

Summary: The complexity of biotherapeutic products requires monitoring and characterization of numerous product quality attributes. Capillary electrophoresis (CE) has been used in biopharmaceutical analysis but is considered low-throughput. In this study, the dead time of CE was utilized to analyze three monoclonal antibody samples, resulting in a significant reduction in analysis time and increased productivity without compromising resolution. Good method reproducibility was observed, suggesting that sequential injections can be applied for fast and robust CE analysis of biopharmaceuticals.

ELECTROPHORESIS (2023)

Review Pharmacology & Pharmacy

A review of therapeutic failures in late-stage clinical trials

Ritu Jain, Janakiraman Subramanian, Anurag S. Rathore

Summary: The drug approval process involves extensive and expensive preclinical and clinical examination. Most drugs fail in late-stage clinical trials due to inability to achieve primary endpoints or intolerable adverse effects. Only one-tenth of the drugs that enter clinical trials progress to FDA regulatory submission.

EXPERT OPINION ON PHARMACOTHERAPY (2023)

Article Biotechnology & Applied Microbiology

Role of oxidative stress in modulating CHO cell culture performance: Impact on titer and quality attributes of a monoclonal antibody therapeutic

Rajinder Kaur, Anurag S. Rathore

Summary: This study demonstrates that the addition of antioxidants in cell culture can reduce ROS levels, increase mitochondrial membrane potential, improve cell viability, reduce apoptosis and lysosome activity. Furthermore, antioxidants can enhance antibody production and improve its quality.

JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY (2023)

Article Chemistry, Analytical

Rapid Estimation of Size-Based Heterogeneity in Monoclonal Antibodies by Machine Learning-Enhanced Dynamic Light Scattering

Anuj Shrivastava, Shyamapada Mandal, Sudip K. Pattanayek, Anurag S. Rathore

Summary: Aggregation of monoclonal antibody therapeutics is a serious concern. A new approach using dynamic light scattering (DLS) and machine learning (ML) algorithm is proposed to quantify the relative percentage of multimers in a monoclonal antibody therapeutic product.

ANALYTICAL CHEMISTRY (2023)

Review Biotechnology & Applied Microbiology

Advances in bioreactor control for production of biotherapeutic products

Saxena Nikita, Somesh Mishra, Keshari Gupta, Venkataramana Runkana, James Gomes, Anurag S. Rathore

Summary: Advanced control strategies have been widely implemented in chemical, pharmaceutical, and food processing industries. Recently, there has been exploration of applying these strategies to bioreactor control for the production of biotherapeutics. The development of a robust and advanced process control system, aided by advancements in sensors, machinery, and industrial internet of things, can greatly improve bioreactor process performance, productivity, and reproducibility. This review discusses the advancements, challenges, and future prospects for control strategies in industrial-scale production of biotherapeutic products.

BIOTECHNOLOGY AND BIOENGINEERING (2023)

Article Medicine, Research & Experimental

Combined Presence of Ferrous Ions and Hydrogen Peroxide in Normal Saline and In Vitro Models Induces Enhanced Aggregation of Therapeutic IgG due to Hydroxyl Radicals

Shravan Sreenivasan, Anurag S. Rathore

Summary: This study investigated the aggregation of mAb in the presence of Fe2+ and H2O2 in saline and in vitro models. The results showed that the combined presence of Fe2+ and H2O2 increased mAb aggregation and altered protein structure and hydrophobicity. Increasing the time, temperature, and Fe2+ and H2O2 concentration further enhanced mAb aggregation. Additionally, mAb samples with copper and cobalt chlorides also resulted in degradation.

MOLECULAR PHARMACEUTICS (2023)

Article Biochemistry & Molecular Biology

An efficient computational protocol for template-based design of peptides that inhibit interactions involving SARS-CoV-2 proteins

Akshay Chenna, Wajihul Hasan Khan, Rozaleen Dash, Saurabh Saraswat, Archana Chugh, Anurag S. Rathore, Gaurav Goel

Summary: This study used a structural bioinformatics protocol to design peptides that can inhibit the complexation of SARS-CoV-2 RdRp. Two designed peptides with high geometric complementarity and interaction specificity for the binding interface of nsp7 were identified. These peptides showed better binding affinity than nsp12 and effectively inhibited the complexation of nsp7-nsp12.

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2023)

Article Chemistry, Analytical

Near-infrared spectroscopy based monitoring of all 20 amino acids in mammalian cell culture broth

Geetanjali Basavaraj Hubli, Shantanu Banerjee, Anurag S. Rathore

Summary: In this study, a robust FT-NIR based quantification method has been developed for the measurement of all 20 amino acids, glucose, lactate, and trastuzumab in CHO cell culture. The method achieved good calibration statistics and demonstrated the ability to accurately predict the concentrations of these components. The proposed tool has the potential to play a critical role in biopharmaceutical manufacturing and process control.

TALANTA (2023)

Article Public, Environmental & Occupational Health

Emerging themes and factors influencing the prices of biotherapeutics

Sonia Gandhi, Smita Kashiramka, Anurag S. Rathore

Summary: The high prices of biotherapeutics are a concern for agencies working on strategies to manage medicine prices and promote equitable access. This study identifies factors influencing the price of biotherapeutics, highlighting the importance of considering innovation capability, development costs, and regulatory environment. Policymakers need to implement innovative pricing frameworks that align with national policies, regulations, and market dynamics.

WORLD MEDICAL & HEALTH POLICY (2023)

Article Biotechnology & Applied Microbiology

A novel method for continuous chromatographic separation of monoclonal antibody charge variants by combining displacement mode chromatography and step elution

Anupa Anupa, Vikrant Bansode, Nikhil Kateja, Anurag S. Rathore

Summary: This article presents a novel approach for the separation of charge variants during continuous CEX chromatography. By combining displacement mode chromatography and salt-based step elution, the content of acidic and basic variants is effectively controlled. Compared to traditional methods, this approach increases resin productivity and utilization, while achieving high recovery rates.

BIOTECHNOLOGY PROGRESS (2023)

暂无数据